Page last updated: 2024-10-24

verapamil and Bone Marrow Diseases

verapamil has been researched along with Bone Marrow Diseases in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciaudo, M1
Chauvenet, L1
Audouin, J1
Rossert, J1
Favier, R1
Horellou, MH1
Bernadou, A1
Samama, M1
Bleifeld, W1
Merx, W1
Effert, S1

Other Studies

2 other studies available for verapamil and Bone Marrow Diseases

ArticleYear
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
    Leukemia & lymphoma, 1995, Volume: 19, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cy

1995
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
    Deutsche medizinische Wochenschrift (1946), 1971, Apr-16, Volume: 96, Issue:16

    Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous Sys

1971